San Francisco, October 22, 2026 /PRNewswire/ — Alethios, a software platform providing research infrastructure for human health studies, today launched a comprehensive suite of decentralized data collection tools. Researchers can now integrate patient-reported outcomes, wearable and sensor data, digital biomarkers, and at-home biomarker tests into a single study—without writing code, managing multiple vendors, or requiring clinic visits.
Alethios supports research in the fields of nutritional supplements, functional foods, academia, consumer health, medical devices, biotechnology, and life sciences. Research designs—from consumer perception studies to pivotal, randomized, double-blind, placebo-controlled trials—can all be conducted on the same software platform. Customers including Givaudan, Thorne, PLT Health Solutions, Applied Food Sciences, Hofseth BioCare, Helaina, Samphire Neuroscience, and Sonoran University are using the platform to generate rigorous evidence from participants’ homes. The new integration is built on the company’s founding belief: rigorous, multimodal research should be accessible to teams of all sizes and budgets and encompass the entire human health ecosystem.


This kit covers four layers of data, each of which can be used as a no-code integration in Alethios Study Planner and Study Operator:
- Report data: photos, videos, audio, and text submitted by participants, along with a library of clinically validated scales, including both publicly available and licensed scales.
- Generated health data: personal wearable devices and health platforms, including Apple Watch, Google Health, Garmin, Oura, Whoop, and Fitbit, as well as sensors such as Abbott’s continuous glucose monitor, and Withings and InBody bioimpedance scales.
- Digital biomarkers: validated cognitive assessments powered by BrainHQ, skin health selfies powered by Haut.ai for dermatological and cosmetic research, and 3D body composition scans powered by Prism Labs.
- At-home biomarker testing: dried blood spot cards, Tasso blood collection devices, and at-home microbiome kits. Standard tests include male and female hormones, cardiovascular, metabolic, inflammatory markers, vitamin D, and hydration status, processed by Choose Health. Next-generation tests include epigenetic clocks from Muhdo and TruDiagnostic, and gut and vaginal microbiome sequencing from GutID and other shotgun metagenomic sequencing partners.
Adding a data type takes just a few clicks. In Study Planner, researchers select the required data types for their study and schedule each one onto participants' timelines. For at-home kits, Alethios handles ordering, shipping, and unique ID verification to ensure each sample is matched to the correct participant, with results then flowing back to the platform. Once the study is live, the Study Operator consolidates all data streams into a single real-time monitoring dashboard.
Default compliant data collection
Each integration on the platform operates on existing infrastructure, with built-in validation and data integrity safeguards, and every design is intended to encourage participant adherence without compromising data quality. Researchers can:
- Schedule each integration on the research timeline so that each data point is accurately timestamped.
- Link completion and compliance to milestone-based tracking and compensation, such as issuing a $50 gift card after the participant's kit is received by the laboratory.
- Use Study Operator to monitor compliance across multiple data types in real time, identifying issues before wearable syncs are missed, surveys are delayed, or kits are not returned—preventing them from becoming missing data.
- Each data point is automatically cleaned and aligned with the corresponding subject, so the research team receives a ready-to-analyze dataset rather than having to stitch together data exported from multiple vendors.
“We built Alethios for researchers across the entire human health field,” said Zeenia Framroze, founder and CEO of Alethios. “With so many new ways to collect home-based data, we want to provide research teams with the best tools available, no matter where they are. Whether someone is designing efficacy validation studies for supplements or conducting post-market surveillance for pharmaceuticals, we want to make it easy for them to gather robust subjective and objective data from Alethiad participants across the country. The better and more accessible the data collection, the more we can advance our understanding of human health as a whole.”
The foundation of the next generation of health measurement
"With so many new devices and at-home tests currently under development," said Gurpreet Atwal, Chief Technology Officer at Alethios, "we want Alethios to serve as a tool for scientists and innovators to rapidly develop and validate new data collection methods, and as a hub for the latest and most advanced technologies in human health measurement. With the rapid recruitment capabilities of the Alethiad Participant Community, these technologies can be tested from day one on diverse, representative participant populations."
Companies developing new devices, tests, or digital biomarkers may apply here for integration with Alethios.
About Alethios
Alethios is a software platform that provides infrastructure for human health research. Its AI-driven, full-stack software delivers the capabilities of a dedicated research team at a fraction of the management cost. The platform unifies protocol design, IRB coordination, recruitment, participant management, multimodal data collection, and decentralized clinical trial reporting. Principal investigators, sponsors, and CROs rely on Alethios to generate rigorous real-world evidence across the human health industry, with studies deployable in minutes and plans starting at just $100 per month. Through Study Planner, Study Operator, and the Alethiad Participant Community, research teams can use the software in self-service, hybrid, or fully managed modes—at a fraction of the cost of traditional research. Alethios is a 2026 Nutra Healthspan Innovator Award winner, a finalist in the 2026 Vitafoods Europe Startup Challenge, and a finalist in the 2025 NutraIngredients-USA Startup Award. For more information, visit Alethios.com.

